Literature DB >> 22481282

Intra-tumoral budding in preoperative biopsy specimens predicts lymph node and distant metastasis in patients with colorectal cancer.

Olivier T Giger1, Sarah C M Comtesse, Alessandro Lugli, Inti Zlobec, Michael O Kurrer.   

Abstract

Tumor budding, a histological hallmark of epithelial-mesenchymal transition in colorectal cancer, is a parameter of tumor progression and according to the International Union Against Cancer/American Joint Committee on Cancer an 'additional' prognostic factor. The current definition of tumor budding is reserved for the invasive tumor front of colorectal cancer (so called peri-tumoral budding), but tumor buds can also be observed in small preoperative biopsy specimens. Whereas the prognostic value of peri-tumoral budding assessed in resection specimens has found wide acceptance, the value of budding in preoperative biopsies, which normally do not encompass the invasive tumor margin and hence can be called intra-tumoral budding, has not been systematically investigated yet. Therefore, the aim of this study is to assess the predictive value of intra-tumoral budding for lymph node and distant metastasis in preoperative biopsies. Preoperative biopsy samples and consecutive resection specimens from 72 patients with pathological information on TNM stage, vascular, lymphatic and perineural invasion, and tumor border configuration were used to evaluate intra-tumoral budding and peri-tumoral budding. Both parameters were scored semiquantitatively as 'high' (detectable at low power magnification × 2.5) and 'low' (occasional budding at intermediate magnification × 10, difficult to find or absent). In biopsy samples high intra-tumoral budding was observed in 12/72 patients (17%) and associated with high peri-tumoral budding in the corresponding resection specimens (P=0.008). Additionally, there was a correlation between high intra-tumoral budding and lymph node metastasis (P=0.034), distant metastasis (P=0.007) and higher tumor grade (P=0.025). Peri-tumoral budding was associated with higher N stage (P=0.004), vascular (P=0.046) and lymphatic invasion (P=0.019) as well as with an infiltrating tumor border (P<0.001), reflecting the predictive power of peri-tumoral budding for tumor progression. High intra-tumoral budding in preoperative biopsy samples of colorectal cancer patients predicts high peri-tumoral budding at the invasive margin and lymph node metastasis in the corresponding resection specimens as well as distant metastasis.

Entities:  

Mesh:

Year:  2012        PMID: 22481282     DOI: 10.1038/modpathol.2012.56

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  32 in total

1.  IMP3 expression in biopsy specimens of colorectal cancer predicts lymph node metastasis and TNM stage.

Authors:  Qingzhu Wei; Xiaoping Huang; Bo Fu; Jianghuan Liu; Ling Zhong; Qiao Yang; Tong Zhao
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

Review 2.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

3.  Tumor budding as a potential histopathological biomarker in colorectal cancer: hype or hope?

Authors:  Fabio Grizzi; Giuseppe Celesti; Gianluca Basso; Luigi Laghi
Journal:  World J Gastroenterol       Date:  2012-12-07       Impact factor: 5.742

Review 4.  Tumour budding in solid cancers.

Authors:  Alessandro Lugli; Inti Zlobec; Martin D Berger; Richard Kirsch; Iris D Nagtegaal
Journal:  Nat Rev Clin Oncol       Date:  2020-09-08       Impact factor: 66.675

5.  Tumor budding in colorectal cancer revisited: results of a multicenter interobserver study.

Authors:  Viktor H Koelzer; Inti Zlobec; Martin D Berger; Gieri Cathomas; Heather Dawson; Klaus Dirschmid; Marion Hädrich; Daniel Inderbitzin; Felix Offner; Giacomo Puppa; Walter Seelentag; Beat Schnüriger; Luigi Tornillo; Alessandro Lugli
Journal:  Virchows Arch       Date:  2015-02-21       Impact factor: 4.064

6.  Prognostic Significance of Lacunarity in Preoperative Biopsy of Colorectal Cancer.

Authors:  Gorana Aralica; Martina Šarec Ivelj; Arijana Pačić; Josip Baković; Marija Milković Periša; Anteja Krištić; Paško Konjevoda
Journal:  Pathol Oncol Res       Date:  2020-07-02       Impact factor: 3.201

Review 7.  Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016.

Authors:  Alessandro Lugli; Richard Kirsch; Yoichi Ajioka; Fred Bosman; Gieri Cathomas; Heather Dawson; Hala El Zimaity; Jean-François Fléjou; Tine Plato Hansen; Arndt Hartmann; Sanjay Kakar; Cord Langner; Iris Nagtegaal; Giacomo Puppa; Robert Riddell; Ari Ristimäki; Kieran Sheahan; Thomas Smyrk; Kenichi Sugihara; Benoît Terris; Hideki Ueno; Michael Vieth; Inti Zlobec; Phil Quirke
Journal:  Mod Pathol       Date:  2017-05-26       Impact factor: 7.842

Review 8.  Tumour budding: a promising parameter in colorectal cancer.

Authors:  A Lugli; E Karamitopoulou; I Zlobec
Journal:  Br J Cancer       Date:  2012-04-24       Impact factor: 7.640

Review 9.  Is there still a place for conventional histopathology in the age of molecular medicine? Laurén classification, inflammatory infiltration and other current topics in gastric cancer diagnosis and prognosis.

Authors:  Cristina Díaz Del Arco; Luis Ortega Medina; Lourdes Estrada Muñoz; Soledad García Gómez de Las Heras; Mª Jesús Fernández Aceñero
Journal:  Histol Histopathol       Date:  2021-02-10       Impact factor: 2.303

10.  Role of intra- and peritumoral budding in the interdisciplinary management of rectal cancer patients.

Authors:  Inti Zlobec; Markus Borner; Alessandro Lugli; Daniel Inderbitzin
Journal:  Int J Surg Oncol       Date:  2012-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.